Science, Technology and Superpowers

Cooperation in Science and Technology: An Evaluation of the U.S.-Soviet Agreement. Catherine P. AiIes and Arthur E. Pardee Jr. Westview Press, Boulder, CO, 1986. 368 pp. $28.50. After-the-fact appraisal of the 1972-82 intergovernmental agreement on scientific and technical exchanges between the superpowers turns out to present the old question of whether the glass was half full or half empty relative to what was hoped for. SRI International analyst Catherine Ailes and consultant Arthur Pardee Jr

Written byWilliam Carey
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Within the umbrella agreement signed by the two powers in 1972, 11 working group programs were launched by the Americans and the Soviets as joint efforts. Steering responsibilities were shared between the White House Office of Science and Technology and the U.S.S.R. State Committee on Science and Technology, through a Joint Commission. So far, so good. But auspicious beginnings announced at summit meetings and keyed to political objectives with science employed as an instrument of convenience are at the mercy of the foul-up factor, in this case the unsteady equilibrium of overall political relations.

Of the 11 working parties, a few hit the ground running and accomplished respectable results. Several others slipped and slid through the muddy terrain with little to show by the time the curtain dropped, and a few late-starters were cut off at the pass when the basic agreement met sudden death in the wake of the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies